MRK : Analysis & Opinions

  1. Clinical Trial Hopes Drugs Help Body Fight Cancer

    January 18, 2017
    Agenus will begin a study that pairs a personalized cancer vaccine with Merck's PD-1 pathway blocker.
  2. Merck KGaA, Palantir Team Up for Cancer Data Analytics

    January 17, 2017
    Merck KGaA will use Palantir analytics software to predict which patients will respond best to certain drugs.
  3. These 5 Drug Patents Will Expire in 2017

    January 16, 2017
    Investopedia looks at the top drug patents about to expire in 2017
  4. Dogs of the Dow: Why 2017 Might Be Their Year

    January 11, 2017
    With all eyes focused on the Dow's recent rally, there is one investment strategy that couldn't care less.
  5. Piper Bullish On Pfizer and Eli Lilly

    January 9, 2017
    Today, Piper mentioned that it likes Pfizer and Eli Lilly and is less a favorable on Merck and Johnson & Johnson.
  6. Merck Stock Trades Ex-Dividend Tuesday

    December 13, 2016
    Merck will send its dividend payment on Jan. 9 to shareholders of record as of Dec. 15.
  7. Beyond Dow 20,000: More Gains Ahead

    December 12, 2016
    Bullish: The Dow is just 1% shy of 20,000 and more gains are likely after outperforming in 2016
  8. FDA Grants Merck Priority Review for Keytruda Drug (MRK)

    November 28, 2016
    Merck is looking to expand its cancer drug to become the first-line treatment of patients with advanced non-small cell lung ...
  9. Merck Bumps Its Dividend Higher

    November 23, 2016
    Big pharmaceutical firm Merck (NYSE: MRK) is adding a dollop of change to its dividend. The company announced that it will ...
  10. Merck Declares 47-Cent Quarterly Dividend (MRK)

    November 23, 2016
    Merck's board has declared a quarterly dividend of 47 cents per share payable on Jan. 9, 2017, to shareholders of record ...
  11. Merck Announces Dividend Increase, Offering Attractive Yield ...

    November 23, 2016
    On November 22nd, 2016 Merck announced it was increasing it dividend.
  12. Merck to Launch HPV Cancer Drug Combo Study (MRK)

    November 17, 2016
    The combination therapy involving Merck’s Keytruda and Genexine’s cancer vaccine takes a shot at treating HPV-induced cancers
  13. Merck Developing New Products with OpGen (MRK)

    November 15, 2016
    Merck entered into a collaboration with OpGen to create new products and remains encouraged by phase II testing results on ...
  14. Inside the Health Care Select SPDR ETF: Merck (MRK, XLV)

    November 14, 2016
    Coming at No. 3 on the weighting list, Merck is one of several health care giants within the Health Care Select Sector SPDR ...
  15. Drug Stocks Rebound After Clinton Defeat (PFE, MRK)

    November 10, 2016
    Drug and biotech stocks rebounded sharply after the Trump victory. Hillary Clinton had pledged to stop escalating prices, ...
  16. Adaptimmune, Merck to Test Cancer Drug (ADAP, MRK)

    October 30, 2016
    Adaptimmune Therapeutics and Merck are launching a joint cancer drug study to treat multiple myeloma.
  17. Merck Set For Big Move After 3-Month Slumber (MRK)

    October 21, 2016
    Merck hasn't budged since gapping up in early August, with the October 25th earnings report set to trigger much higher or ...
  18. Competition Fuels Aetna, Merck Deal (AET, MRK)

    October 14, 2016
    In an effort to boost sales of its diabetes drugs, Merck inks value-based contract to ensure preferred status with insurance ...
  19. MRK: How Merck's Stock Price Rose 31.42% in 6 Months

    September 3, 2016
    After sinking 6.99% during calendar year 2015, Merck's stock price soared 31.42% during the six-month period between Feb. ...
  20. Top 5 Corporate Donors in Big Pharma (GILD, MRK)

    July 29, 2016
    Gilead Sciences, Merck and Pfizer were among the biggest corporate cash donors from the drug and health care sector last ...
  21. Merck Stock Trades Ex-Dividend Monday (MRK)

    June 13, 2016
    Merck will send its dividend payment on July 8 to shareholders of record as of June 15.
  22. Merck Testing 13-Year Resistance (MRK)

    June 10, 2016
    Merck has entered the third-year of a critical test at 13-year resistance in the low 60s.
  23. The 3 Largest Health Care ETFs (XLV, IBB)

    April 25, 2016
    Find out which exchange-traded funds (ETFs) are the largest in terms of total assets under management (AUM) in the health ...
  24. Valeant vs. Abbott Labs: Which Is Better for My Portfolio? (VRX, ...

    April 16, 2016
    Explore the differences between Abbott Laboratories and Valeant Pharmaceuticals, as well as which stock is the best addition ...
  25. Gilead Sciences Rise on Hepatitis C Strength (GILD, MRK)

    April 4, 2016
    Gilead's hepatitis C franchise will prove durable in the face of increased competition, analysts believe.
  26. 3 Best Dividend-Paying U.S. Health Care Mutual Funds (VGHCX, ...

    April 2, 2016
    Find out which mutual funds are paying the highest dividend yields in the health care sector, which has underperformed all ...
  27. Whole Foods Taking Slow Growth Path With Chickens

    March 21, 2016
    The commitment toward better animal husbandry continues to grow with Whole Foods Market (NASDAQ: WFM) announcement that ...
  28. VWINX: Overview of Vanguard Wellesley Income Fund

    March 19, 2016
    Learn the highlights of the Vanguard Wellesley Income Fund in this overview, including its investment objective, management ...
  29. (VHT) Vanguard Healthcare ETF: Top 5 Holdings

    March 19, 2016
    Identify the top five holdings in the Vanguard Health Care exchange-traded fund (ETF), and evaluate each holding's business ...
  30. 4 Defensive ETFs Worth Your While (VHT, PGX)

    March 19, 2016
    Find out which top exchange-traded funds (ETFs) would be well worth your consideration when deploying a defensive investment ...
  31. (XLV) Healthcare SPDR ETF: Top 5 Holdings

    March 18, 2016
    Discover the top five stocks in the Health Care Select Sector SPDR Fund, and learn if they can help power your portfolio ...
  32. The 5 Highest Paid Executives in the Healthcare Sector (AGN, ...

    March 18, 2016
    Discover who the highest paid executives in the health care sector are and how much they make, while the cost of health care ...
  33. The 3 Biggest Healthcare Stocks in the S&P 500 ETF (SPY, JNJ)

    March 17, 2016
    Discover the three biggest health care companies in the SPY ETF, and learn how they could power your portfolio performance ...
  34. How Merck and Daktari Are Working together to Create the HCV ...

    March 12, 2016
    Find out why Merck invested in privately owned Daktari Diagnostics, a company working on a Hepatitis C diagnostics test. ...
  35. J&J's Partnership with IBM Could Turn Profitable (JNJ, IBM)

    March 12, 2016
    Learn why Johnson & Johnson teamed up with IBM, and which patient mobile apps will be part of their medical data analysis ...
  36. Is Big Pharma Under Pressure in 2016? (JNJ, GSK)

    March 8, 2016
    Find out why large pharmaceutical companies are coming under pressure by investors to break themselves up into smaller companies.
  37. Cerus Corp. May Have Treatment For Zika Virus

    February 4, 2016
    There might be a cure for the Zika virus which is starting to garner widespread media attention as the threat of the mosquito ...
  38. How Novartis Probably Has a Cure for What Ails You

    January 21, 2016
    A look at the unparalleled growth of the world's biggest pharmaceutical company: Novartis AG.
  39. The World's Top 10 Biotechnology Companies (JNJ, ROG.VX)

    December 22, 2015
    Learn how the marriage of science and technology is changing the world of medicine and creating some of the largest multinational ...
  40. FDA's Warning Shakes Up Hep C Landscape

    October 23, 2015
    Yesterday, the FDA issued a warning highlighting the risk of potential serious liver injury with Viekira Pak, a drug used ...
  41. The 5 Best Dividend Stocks in the Healthcare Sector (GSK, ABBV)

    October 7, 2015
    Learn about the top five dividend stocks of companies operating in the health care sector that generate substantial cash ...
  42. Pfizer Stock Is Like An Extended Release Drug

    August 12, 2015
    Pfizer is a leading research-driven pharmaceutical company, but how good is its financial health?
  43. Make Room for Exelixis in Your Portfolio

    August 12, 2015
    Discover information and analysis on the biopharmaceutical company, Exelixis, and learn what makes it a good stock to consider ...
  44. Apple's New Business: Bonds

    June 26, 2015
    Apple and Oracle are using their massive cash piles to buy up corporate debt. With bond markets looking increasingly rickety, ...
  45. Merck Takes Aim at Gilead. Should You Worry? (GILD, MRK)

    May 29, 2015
    The battle for hepatitis C dominance is about to get even more interesting for investors over the coming year. That's because ...
  46. Who are Gilead Sciences' (GILD) main competitors?

    May 22, 2015
    Learn about the pharmaceutical company Gilead Sciences and its main competitors. Explore the company's role in creating HIV-preventing ...
  47. Who are Pfizer's (PFE) main competitors?

    May 20, 2015
    Learn about Pfizer's place in the pharmaceutical industry, and find out which major drug manufacturers are among its main ...
  48. Houston, Johnson & Johnson May Have a Problem (JNJ, AZN)

    May 19, 2015
    When it comes to potential "safe haven" investments, healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is often ...
  49. A Quick Guide To Healthcare ETFs

    May 8, 2015
    The healthcare industry offers a broad variety of sector ETFs but it’s difficult to avoid exposure to pharmaceuticals and ...
  50. Why Merck's Victory Is of Little Concern to Gilead (GILD, MRK)

    April 10, 2015
    Merck (NYSE: MRK) investors can be proud, as the company's persistence appears to be paying off. While Gilead Sciences (NASDAQ: ...
  51. 3 Moves Pfizer Should Make for Its Shareholders (PFE, JAZZ)

    April 7, 2015
    PFE data by YCharts. Big pharmaceutical giant Pfizer (NYSE: PFE) isn't often thought of as a substantial growth driver of ...
  52. What are examples of major companies in the drugs sector?

    April 1, 2015
    Identify the major players in the drugs sector, which include many established pharmaceutical companies that have delved ...
  53. How is a Spinoff Worth $100 Billion? See AbbVie

    April 1, 2015
    An in depth look at Abbott Labs spinoff AbbVie and how it became a nearly $100 billion company.
  54. Interested In Pharmaceutical Stocks? Try Novartis (ADR)

    February 26, 2015
    Novartis AG, is the world's leading pharmaceutical company by sales. Here is a closer look at Novartis, and how its financials ...
  55. The Best Way Into Big Pharma? See This ETF (IHE)

    November 21, 2014
    Pharma investing isn't for everyone, but sector-specific ETFs, such as the iShares Dow Jones U.S. Pharmaceuticals ETF (IHE), ...
  56. How Merck Found Its Way Into Millions Of Medicine Cabinets

    September 15, 2014
    With over $40 billion in revenue from pharmaceutical sales, there's a good chance that you'll be very grateful for one of ...
  57. Will Immunotherapy Disrupt The Oncology Market?

    August 20, 2013
    Immunotherapy could radically change the treatment of cancer, and the revenue opportunities for pharmaceutical companies.
  58. After A Good Run, Novartis Looks Fairly Valued

    June 12, 2013
    Novartis is a well-balanced, high-quality pharma with growth credentials, but also a fair valuation today.
  59. The “Healthy” Play In Contract Research Organizations

    April 17, 2013
    The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is mundane ...
  60. Birth Control Subsidies Slashed: Will Big Pharma Take A Hit?

    March 6, 2012
    Several states have already slashed birth control subsidies. Learn how this will affect pharmaceutical stocks.
  61. Novo Nordisk Still One Of The Best Around

    May 3, 2011
    Novo Nordisk is one of the best pharmaceutical companies in the world - and it's priced accordingly.
  62. 7 Reasons To Pick ETFs Over Stocks

    November 1, 2010
    As a cost-effective way to achieve a broadly diversified portfolio, including hard-to-own (but worthwhile) assets, ETFs are ...
  63. Is Pfizer What The Doctor Ordered Or Bad Medicine?

    April 30, 2009
    Explore Pfizer, its earnings and its recent acquisition deal.